Toyama Medical Journal
Online ISSN : 2758-819X
Print ISSN : 1883-2067
CASE REPORT
Acyclovir-related neurotoxicity induced by valacyclovir ―two case report―
Mio TSUTSUITakashi ASAHIMasahiro WAKASUGIDaisuke TANGESeisuke OKAZAWAHiroshi OKUDERA
Author information
JOURNAL FREE ACCESS

2007 Volume 17 Issue 1 Pages 33-36

Details
Abstract
 Valacyclovir (VACV) is a prodrug of acyclovir and well known as an effective medicine for the treatment of herpes zoster, however, acyclovir neurotoxicity rarely appears as a side-effect. We wish to report on two cases of neurotoxicity caused by oral VACV administration which they have dealt with, together with several bibliographical comments. Case 1: A 78-year-old female patient, without renal failure, was prescribed VACV at a dose of 3000mg per day. Five days later, disturbance of consciousness appeared, and she came to our hospital the next day. Acyclovir neurotoxicity and acute renal failure were suspected, because disturbance of consciousness and renal failure completely improved within several days after discontinuation of VACV administration. Case 2: A 73-year-old male patient, on hemodialysis third a week, was prescribed VACV at a dose of 3000mg per day. Two days later, psychiatric disorder appeared and he came to our hospital by ambulance. Acyclovir neurotoxicity due to overdosage was suspected. Administration of VACV was discontinued and hemodialysis was performed. A few days later, the symptoms were completely disappeared. It is important to remind acyclovir neurotoxicity when patient has disturbance of consciousness or psychiatric disorder following administration of VACV.
Content from these authors
© 2006 Toyama University Medical Association
Previous article Next article
feedback
Top